Bupivacaine
- Generic Name
- Bupivacaine
- Brand Names
- Exparel, Kenalog, Marbeta, Marcaine, Marcaine With Epinephrine, Marvona Suik, P-Care M, P-Care MG, P-care, Posimir, Readysharp Anesthetics Plus Ketorolac, Readysharp-A, Readysharp-p40, Readysharp-p80, Sensorcaine, Sensorcaine With Epinephrine, Vivacaine, Xaracoll, Exparel liposomal
- Drug Type
- Small Molecule
- Chemical Formula
- C18H28N2O
- CAS Number
- 38396-39-3
- Unique Ingredient Identifier
- Y8335394RO
- Background
Bupivacaine is a widely used local anesthetic agent.
- Indication
As an implant, bupivacaine is indicated in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.
...
- Associated Conditions
- Acute Gouty Arthritis, Adrenocortical Insufficiency, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Berylliosis, Bullous dermatitis herpetiformis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Dermatomyositis (DM), Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Hemolytic Anemia, Hypercalcemia caused by Cancer, Keloids Scars, Leukemias, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Ocular Inflammation, Ophthalmia, Sympathetic, Osteoarthritis (OA), Pain, Labor, Polymyositis, Postoperative pain, Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Regional Enteritis, Rheumatoid Arthritis, Secondary thrombocytopenia, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Trichinosis, Tuberculous Meningitis, Ulcerative Colitis, Uveitis, Acute Bursitis, Acute Idiopathic Nephrotic Syndrome, Acute Lupus Erythematosus, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute nonspecific tenosynovitis, Cystic tumors of aponeurosis, Cystic tumors of tendon, Disseminated Pulmonary Tuberculosis (TB), Exfoliative erythroderma, Inflammatory lesions of granuloma annulare, Inflammatory lesions of lichen planus, Inflammatory lesions of lichen simplex, Non-suppurative Thyroiditis, Permphigus, Severe Allergic Reactions
- Associated Therapies
- General Anesthesia, Local Anaesthesia therapy, Regional nerve block therapy
Bupivacaine Versus Bupivacaine Plus Lidocaine in Infraclavicular Block
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-04-27
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Hospital de San Carlos Dr. Benicio Arzola Medina
- Target Recruit Count
- 40
- Registration Number
- NCT05834023
- Locations
- 🇨🇱
Hospital de San Carlos Dr. Benicio Arzola Medina, San Carlos, Ñuble, Chile
Clonidine for Infra-orbital Nerve Block During Pediatric Cleft Lip Revision Surgeries
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 86
- Registration Number
- NCT05790044
Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- Mansoura University
- Target Recruit Count
- 58
- Registration Number
- NCT05785377
- Locations
- 🇪🇬
Mansoura University-Emergency hospital-ICU, El Mansoura, Mansoura, Egypt
Comparative Study to Evaluate the Efficacy of Ultrasound-Guided Pericapsular Nerve Group (PENG) Block Versus Fascia Iliaca Compartment (FIC) Block on the Postoperative Analgesic Effect in Patients Undergoing Hip Surgeries Under Spinal Anesthesia.
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- Sohag University
- Target Recruit Count
- 42
- Registration Number
- NCT05751291
- Locations
- 🇪🇬
Sohag University Hospital, Sohag, Egypt
Steroids in Occipital Nerve Block for Treatment of Headache
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-02-17
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 120
- Registration Number
- NCT05732532
- Locations
- 🇺🇸
Mayo Clinic Minnesota, Rochester, Minnesota, United States
Dexmedetomedine and Ketamine in Erector Spinae Block for Postoperative Analgesia Following Mastectomy.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-02-14
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- National Cancer Institute, Egypt
- Target Recruit Count
- 75
- Registration Number
- NCT05727098
- Locations
- 🇪🇬
Hanafy, Cairo, Egypt
Sphenopalatine Ganglion Block Study
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-02-01
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 220
- Registration Number
- NCT05707754
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Erector Spinae Plane Block and Ankle and Foot Surgery
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-02-01
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Fayoum University Hospital
- Target Recruit Count
- 68
- Registration Number
- NCT05708742
- Locations
- 🇪🇬
Fayoum University hospital, Madīnat al Fayyūm, Faiyum Governorate, Egypt
The Analgesic Efficacy of Two Bupivacaine Concentrations for Combined Ilioinguinal and Iliohypogastric Nerve Block in Postherniorrhaphy Pain
Early Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 90
- Registration Number
- NCT05687981
Pain Control After Arthroscopic Shoulder Surgeries
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 90
- Registration Number
- NCT05686395
- Locations
- 🇪🇬
Faculty of Medicine Tanta University, Tanta, Egypt
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath